The safety of psilocybin-assisted psychotherapy: A systematic review
Australian & New Zealand Journal of Psychiatry December 13, 2024 Rosana Freitas, Efstathia Stephanie Gotsis, Alexander T. Gallo et al. 14 citations
Introduction: Psilocybin, a classical psychedelic, has been rescheduled for use in psilocybin-assisted psychotherapy for treatment-resistant depression in Australia. While evidence for its use is promising, understanding the associated risks is crucial. Accordingly, this review aims to collate adverse event data from psilocybin-assisted psychotherapy clinical trials and evaluate its definition,...